Concepedia

Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: Results of a randomized, double‐blind, vehicle‐controlled study

Markus Dawid, Marge Veensalu, Maximilian A. Grassberger, Klaus Wolff

JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2006 · 51 citations · 7 references

DOI

Abstract

In this group of adult patients with symmetrical vitiligo, treatment of body lesions (except face) with pimecrolimus cream 1% could not be shown to be effective.

References

7

Fitzpatrick's Dermatology in General Medicine.

Neil Cox · British Journal of Dermatology · 2004 · 1.2K citations

, , +1

Efficacy and Safety of Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Children

Ulrich Wahn, Jan D. Bos, Mark Goodfield et al. · PEDIATRICS · 2002 · 402 citations

A Double-blind Randomized Trial of 0.1% Tacrolimus vs 0.05% Clobetasol for the Treatment of Childhood Vitiligo

Verónica Lepe, Benjamín Moncada, Juan Pablo Castanedo-Cázares et al. · Archives of Dermatology · 2003 · 286 citations

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug

Alexander Kapp, Kim Papp, Ann Bingham et al. · Journal of Allergy and Clinical Immunology · 2002 · 276 citations · Full text

, , +8

Association of the Köbner Phenomenon With Disease Activity and Therapeutic Responsiveness in Vitiligo Vulgaris

M.D. Njoo, Pranab K. Das, J. D. Bos et al. · Archives of Dermatology · 1999 · 259 citations